Using the integrated strategy of network pharmacology and greedy algorithms, the important roles of some targets IL6, HMCGR, PPARA, and APOB for management of hyperlipidemia and obesity were highlighted in this work, which was also in accord with the previous publications. Here, APOB is linked to hyperlipidemia.